NCT06833125View on ClinicalTrials.gov

The Prophylactic Effect of Garlic Tablets to Prevent Nosocomial Infections in Intensive Care Unit Patients.

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

April 1, 2026

Conditions
Nosocomial Infection
Interventions
DRUG

Garlic powder standardized to allicin

The intervention is the administration of garlic tablets (Tomex plus 300 mg) two tablets twice daily (which contains 5.4 mg allicin the active ingredient with anibacterial effect) for 6 days just after ICU admission

Trial Locations (1)

21563

Alexandria Main University Hospital, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER